Your browser doesn't support javascript.
loading
A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy.
Yang, Sha; Wu, Gui-Long; Li, Na; Wang, Minghui; Wu, Peixian; He, Yuxuan; Zhou, Wei; Xiao, Hao; Tan, Xiaofeng; Tang, Li; Yang, Qinglai.
Afiliación
  • Yang S; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Wu GL; Cancer Pathology Research Group, Institute of Basic Disease Sciences & Department of Pathology, Xiangnan University, Chenzhou, 423099, Hunan, China.
  • Li N; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Wang M; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Wu P; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • He Y; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Zhou W; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Xiao H; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Tan X; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China.
  • Tang L; Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Cancer Cellular and Molecular Pathology, Hengyang Medical School, Cancer Research Institute, University of South China, Hengyang, 421001, Hunan, China. tanxiaofeng@usc.edu.cn.
  • Yang Q; Key Laboratory of Tropical Medicinal Plant Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, 571158, Hainan, China. tanxiaofeng@usc.edu.cn.
J Nanobiotechnology ; 20(1): 475, 2022 Nov 11.
Article en En | MEDLINE | ID: mdl-36369039
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fotoquimioterapia / Nanopartículas / Neoplasias Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fotoquimioterapia / Nanopartículas / Neoplasias Idioma: En Revista: J Nanobiotechnology Año: 2022 Tipo del documento: Article País de afiliación: China